IGM Biosciences Inc (IGMS)
10.12
-1.10
(-9.76%)
USD |
NASDAQ |
Nov 14, 16:00
11.07
+0.94
(+9.33%)
After-Hours: 18:37
IGM Biosciences Profit Margin (Quarterly): -3.82K% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -3.82K% |
| March 31, 2024 | -10.02K% |
| December 31, 2023 | -9.32K% |
| September 30, 2023 | -12.18K% |
| June 30, 2023 | -14.38K% |
| Date | Value |
|---|---|
| March 31, 2023 | -11.36K% |
| December 31, 2022 | -14.13K% |
| September 30, 2022 | -17.53K% |
| June 30, 2022 | -16.01K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-17.53K%
Minimum
Sep 2022
-3.82K%
Maximum
Jun 2024
-12.08K%
Average
-12.18K%
Median
Sep 2023
Profit Margin (Quarterly) Benchmarks
| Moderna Inc | 0.70% |
| NovaBay Pharmaceuticals Inc | -66.04% |
| Palatin Technologies Inc | -2.36K% |
| iBio Inc | -4.44K% |
| Theriva Biologics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -110.3% |
| Return on Assets | -52.70% |
| Return on Invested Capital | -110.3% |
| Operating Margin (Quarterly) | -4.10K% |
| Return on Net Operating Assets | -301.4% |